• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What Is Just the Right Amount of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema?: Protocol V and the Goldilocks Principle.

作者信息

Grassi Michael A

机构信息

Grassi Retina, Naperville, Illinois.

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago.

出版信息

JAMA Ophthalmol. 2021 Apr 1;139(4):381-382. doi: 10.1001/jamaophthalmol.2021.0013.

DOI:10.1001/jamaophthalmol.2021.0013
PMID:33630044
Abstract
摘要

相似文献

1
What Is Just the Right Amount of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema?: Protocol V and the Goldilocks Principle.糖尿病性黄斑水肿的抗血管内皮生长因子治疗的最佳剂量是多少？：方案V与金发姑娘原则。
JAMA Ophthalmol. 2021 Apr 1;139(4):381-382. doi: 10.1001/jamaophthalmol.2021.0013.
2
The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.雷珠单抗治疗前后糖尿病性黄斑水肿患者的黄斑功能与结构
Doc Ophthalmol. 2016 Apr;132(2):111-22. doi: 10.1007/s10633-016-9531-4. Epub 2016 Mar 21.
3
DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema.糖尿病视网膜病变临床研究网络（DRCR）协议-T：协调1年和2年数据以管理糖尿病性黄斑水肿
Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 1;47(4):308-12. doi: 10.3928/23258160-20160324-01.
4
Hypertensive cerebral hemorrhage with undetectable plasma vascular endothelial growth factor levels in a patient receiving intravitreal injection of aflibercept for bilateral diabetic macular edema: a case report.一名接受玻璃体内注射阿柏西普治疗双侧糖尿病性黄斑水肿的患者发生高血压性脑出血且血浆血管内皮生长因子水平检测不到：病例报告
J Med Case Rep. 2021 Jul 27;15(1):403. doi: 10.1186/s13256-021-02983-3.
5
Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema.玻璃体腔内雷珠单抗对糖尿病黄斑水肿患者视网膜内硬性渗出的影响。
Am J Ophthalmol. 2020 Mar;211:183-190. doi: 10.1016/j.ajo.2019.11.014. Epub 2019 Nov 20.
6
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.玻璃体内注射阿柏西普、贝伐单抗或雷珠单抗治疗伴有视力损害的累及中心的糖尿病性黄斑水肿后持续性黄斑增厚：一项随机临床试验的二次分析。
JAMA Ophthalmol. 2018 Mar 1;136(3):257-269. doi: 10.1001/jamaophthalmol.2017.6565.
7
Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.基线糖尿病视网膜病变状态对玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿初始解剖学反应的影响。
Eye (Lond). 2017 Sep;31(9):1358-1364. doi: 10.1038/eye.2017.69. Epub 2017 Apr 28.
8
Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.糖尿病性黄斑水肿在抗血管内皮生长因子治疗过程中的功能和形态变化。
Acta Ophthalmol. 2013 Nov;91(7):e529-36. doi: 10.1111/aos.12153. Epub 2013 May 7.
9
Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.玻璃体内注射雷珠单抗治疗既往已行玻璃体切割术的糖尿病性黄斑水肿。
Acta Ophthalmol. 2017 Feb;95(1):28-32. doi: 10.1111/aos.13160. Epub 2016 Jul 30.
10
INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.玻璃体内注射地塞米松植入物治疗雷珠单抗治疗后持续存在的糖尿病性黄斑水肿患者。
Retina. 2015 Jul;35(7):1429-35. doi: 10.1097/IAE.0000000000000490.

引用本文的文献

1
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial.左舒必利治疗糖尿病性黄斑水肿的 2 期随机临床试验。
Eye (Lond). 2024 Feb;38(3):520-528. doi: 10.1038/s41433-023-02715-5. Epub 2023 Sep 6.
2
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema.血管造影生物标志物是预测糖尿病性黄斑水肿患者接受玻璃体内注射阿柏西普治疗反应的重要指标。
Sci Rep. 2023 May 19;13(1):8128. doi: 10.1038/s41598-023-35286-2.
3
Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context.
针对累及黄斑中心凹且视力良好的糖尿病性黄斑水肿患者抗血管内皮生长因子治疗的频率和时机：V方案的实际结果
BMJ Open Ophthalmol. 2022 Aug;7(1). doi: 10.1136/bmjophth-2022-000983.
4
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept.阿柏西普治疗累及黄斑中心凹的糖尿病性黄斑水肿时的对比敏感度变化
Clin Ophthalmol. 2021 Nov 11;15:4439-4445. doi: 10.2147/OPTH.S338478. eCollection 2021.